Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 126, Issue 2, 2006, Pages 201-205

  Kurabayashi, Takumi ^a   Suzuki, Mina ^a   Fujita, Kazuyuki ^a   Murakawa, Haruo ^a   Hasegawa, Isao ^a   Tanaka, Kenichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

75 g OGTT; Anovulation; Clomiphene; Insulin resistance; Polycystic ovary syndrome

Indexed keywords

CLOMIFENE CITRATE; GLUCOSE; INSULIN;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENDOCRINE FUNCTION; FEMALE; FEMALE INFERTILITY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 33646797731     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2005.11.005     Document Type: Article

References (26)

1. Franks S. Polycystic ovary syndrome. N Engl J Med 333 (1995) 853-861
2. Dunaif A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med 98 Suppl. 1A (1995) 33S-39S
3. Nestler J.E., Jakubowicz D.J., Evans W.S., and Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338 (1998) 1876-1880
4. Murakawa H., Hasegawa I., Kurabayashi T., and Tanaka K. Polycystic ovary syndrome Insulin resistance and ovulatory responses to clomiphene citrate. J Reprod Med 44 (1999) 23-27
5. Kiddy D.S., Hamilton-Fairley D., Bush A., et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 36 (1992) 105-111
6. Hasegawa I., Murakawa H., Suzuki M., Yamamoto Y., Kurabayashi T., and Tanaka K. Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome. Fertil Steril 71 (1999) 323-327
7. Nestler J.E., Stovall D., Akhter N., Iuorno M.J., and Jakubowicz M.J. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 77 (2002) 209-215
8. Seli E., and Duleba A.J. Optimizing ovulation induction in women with polycystic ovary syndrome. Curr Opin Obstet Gynaecol 14 (2000) 245-254
9. Mitwally M.F., and Casper R.F. Aromatae inhibitors for the treatment of infertility. Expert Opin Invest Drugs 12 (2003) 353-371
10. Pirwany I., and Tulandi T. Laparoscopic treatment of polycystic ovaries: is it time to relinquish the procedure. Fertil Steril 80 (2003) 241-251
11. Imani B., Eijkemans M.J., te Velde E.R., Habbema J.D., and Fauser B.C. Predictors of patients remaining aznovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligomenorrheic infertility. J Clin Endocrinol Metab 83 (1998) 2361-2365
12. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus, Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81:19-25.
13. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diab Care 22 (1999) 1462-1470
14. McLaughlin T., Abbasi F., Cheal K., Chu J., Lamendola C., and Reaven G. Use of metabolic marker to identify overweight individuals who are insulin resistant. Ann Intern Med 139 (2003) 802-809
15. Wild S., Pierpoint T., McKeigue P., and Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 52 (2000) 595-600
16. Cibula D., Cifkova R., Fanta M., Poledne R., Zivny J., and Skibova J. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod 15 (2000) 785-789
17. Legro R.S., Kunselman A.R., Dodson W.C., and Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84 (1999) 165-169
18. Dunaif A., Segal L.R., Futterweit W., and Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 (1989) 1165-1174
19. Legro R.S., Finegood D., and Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83 (1998) 2694-2698
20. Palmert M.R., Gordon C.M., Kartashov A.I., Legro R.S., Emans S.J., and Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 87 (2002) 1017-1023
21. ACOG Bulletin Practice. Polycystic ovary syndrome. Int J Gynecol Obstet 80 (2003) 335-348
22. Meirow D., Yosseppowitch O., Rosler A., et al. Insulin resistant and non-resistant polycystic ovary syndrome represent two clinical and endocrinological subgroups. Hum Reprod 10 (1995) 1951-1956
23. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
24. Shoham Z., Borenstein R., Lunenfeld B., and Pariente C. Hormonal profiles following clomiphene citrate therapy in conception and nonconception cycles. Clin Endocrinol (Oxf) 33 (1990) 271-278
25. Imani B., Eijkemans M.J., te Velde E.R., Habbema J.D., and Fauser B.C. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligomenorrheic infertility. J Clin Endocrinol Metab 84 (1999) 1617-1622
26. Imani B., Eijkemans M.J., te Velde E.R., Habbema J.D., and Fauser B.C. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril 77 (2002) 91-97